Evidence map›Paper›PMID 39044101›Full record

ArticleJournal of patient-reported outcomes2024

Identification of the most relevant aspects of spinal muscular atrophy (SMA) with impact on the quality of life of SMA patients and their caregivers: the PROfuture project, a qualitative study.

Mencía de Lemus, Maria G Cattinari, Samuel I Pascual, Julita Medina, Mar García, Ana Magallón, María Dumont, Pablo Rebollo

Abstract read
In one paragraph

Article in Journal of patient-reported outcomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Body Weight and Range of Motion as Predictors of Trunk Asymmetry in Children With Spinal Muscular Atrophy: A Prospective Functional Assessment.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mencía de LemusFundación Atrofia Muscular Espinal (FundAME), Calle Nuria 93, 1ºC, Madrid, 28034, Spain.
Maria G CattinariFundación Atrofia Muscular Espinal (FundAME), Calle Nuria 93, 1ºC, Madrid, 28034, Spain. cattinari@fundame.net.ORCID 0000-0001-9821-4194
Samuel I PascualDepartment of Neurology, Hospital Universitario La Paz - Madrid, Madrid, Spain.
Julita MedinaRehabilitation and Physical Unit Department, Hospital Sant Joan de Déu, Barcelona, Spain.
Mar GarcíaDepartment of Neurology, Hospital Universitario La Paz - Madrid, Madrid, Spain.
Ana MagallónImfisio, Madrid, Spain.
María DumontFundación Atrofia Muscular Espinal (FundAME), Calle Nuria 93, 1ºC, Madrid, 28034, Spain.
Pablo RebolloIQVIA, Madrid, Spain.

Funding

Biogen PO17947Novartis Gene Therapies PS1905Roche España SP200924002
6 · The paper itself

Abstract

backgroundSMA is a hereditary neuromuscular disease that causes progressive muscle weakness and atrophy. Several studies have shown that the burden of SMA is very high at many levels. Functional assessment tools currently used do not completely address the impact of the disease in patients' life. The objective of this qualitative study was to identify aspects of SMA that are relevant to patients and to design items useful for assessment purposes.

resultsFive focus group sessions were run during an annual SMA families meeting in Madrid, Spain. Focus groups were composed by parents of SMA type I children, sitter children type II-III, parents of sitter children type II-III, adult patients, and parents of walker children. Two trained facilitators conducted the focus groups using a semi-structured guideline to cover previously agreed topics based on the input of a Scientific and Patient Advisory Committee. The guideline was adapted for the different groups. According to what was communicated by participants, SMA entails a high burden of disease for both patients and their parents. Burden was perceived in physical, psychological, and social areas. Patient's physical domain was the most relevant for participants, especially for parents of non-ambulant children, followed by limitations of motor scales to capture all changes, parents psychological burden, treatment expectations and patient's psychological burden. Ten domains were the main areas identified as impacted by the disease: mobility and independence, fatigue and fatigability, infections and hospital consultations, scoliosis and contractures, vulnerability, pain, feeding, time spent in care, breathing, and sleep and rest.

conclusionsThis study confirms the necessity of evaluating other aspects of the disease that are not assessed in the functional motor scale. Measures of other aspects of the disease, such as pain, fatigue, feeding, should be also considered. A patient-reported outcomes instrument measuring such aspects in a valid and reliable way would be very useful. This study generated a list of new items relevant to be systematically measured in the assessment of the impact of SMA on the patients' everyday life.

Indexed as

CaregiversFocus GroupsMuscular Atrophy, SpinalQualitative ResearchQuality of LifeAdolescentAdultChildChild, PreschoolCost of IllnessFemaleHumansMaleMiddle AgedParentsSpainOutcome measuresPatient reported outcomesQuality of lifeScalesSpinal muscular atrophy

Identifiers

PMID39044101
PMCPMC11266339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.